Search

everythinglearnresearchcommunity

for

Search:↓

Minoxidil effectively treats hair loss, especially androgenetic alopecia, but needs more research for better understanding.

Thiopurines help treat IBD but require genetic testing to avoid side effects.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Up to half of people experience itchy scalp, often due to skin conditions like seborrheic dermatitis or psoriasis, and treatments vary based on the specific cause.

Minoxidil effectively treats hair loss, but use cautiously and monitor side effects.

Chronic inflammatory skin diseases are caused by disrupted interactions between skin cells and immune cells.

New treatments for hair loss from alopecia areata may include targeting immune cells, using stem cells, balancing gut bacteria, applying fatty acids, and using JAK inhibitors.

Vitamin D might be involved in the development of alopecia areata and could help in its treatment.

Old drugs like finasteride and spironolactone are being successfully used for hair loss and skin conditions, and many other drugs show promise for new uses in dermatology.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

A gene variant causes patched hair loss in mice, similar to alopecia areata in humans.

The document concludes that various dermatological treatments and drugs can cause skin reactions and side effects.

The model and estimator can predict drug exposure in kidney transplant patients well.

SCD-153 shows promise as an effective topical treatment for alopecia areata.

Derinat may improve hair growth and quality of life in hair loss patients by reducing oxidative stress.

Our microbiome may affect the development of the hair loss condition Alopecia Areata, but more research is needed to understand this relationship.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

Tofacitinib may help treat severe hair loss, but more research is needed.

More research is needed to find the best long-term treatments for Alopecia Areata.

Keratinocytes help heal skin wounds by interacting with immune cells and producing substances that kill pathogens.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Alopecia Areata significantly lowers quality of life and current treatments are inadequate, highlighting a need for better therapies and standardized treatment protocols.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Herbal alternatives like saw palmetto and green tea may offer safe, effective treatment for hormonal hair loss.

Hair follicles are key to treating vitiligo and alopecia areata, but challenges exist.

Bee venom might be a good alternative treatment for various skin conditions because it has many healing properties.

A new botanical treatment improved hair growth and symptoms in lichen planopilaris patients.